Results 321 to 330 of about 273,619 (385)

Risk of major systemic complications in patients with cutaneous vasculitis: A retrospective cohort study. [PDF]

JAAD Int
Mahajan A, Barbieri J, Piette EW.
europepmc   +1 more source

Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING‐Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy

Arthritis &Rheumatology, Volume 77, Issue 8, Page 1087-1091, August 2025.
Objective The objective was to report the safety and efficacy of an anti‐IFNAR1 antibody (anifrolumab) in a patient with STING‐associated vasculopathy with onset in infancy (SAVI) who presented with vasculitic ulcers and systemic inflammation refractory to JAK inhibition (JAKi) and to the interferon‐β–neutralizing monoclonal antibody dazukibart ...
Sara Alehashemi, Bjoern Buehring, Adriana A. de Jesus, Sachin Gaurav, Andre Rastegar, Alexi Baumgardner, Kip Friend, Oluwatobi T. Arisa, William D. Figg, Danielle Fink, Douglas B. Kuhns, Ben Colton, Cody J. Peer, Raphaela Goldbach‐Mansky   +13 more
wiley   +1 more source

Isotype and affinity of anti-myeloperoxidase autoantibodies in systemic vasculitis

, 1994
Ε. Κοκολίνα, Laure‐Hélène Noël, Patrick Nusbaum, C Geffriaud, Jean‐Pierre Grünfeld, Lise Halbwachs‐Mecarelli, Philippe Lesavre   +6 more
openalex   +1 more source

Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis

Arthritis &Rheumatology, Volume 77, Issue 8, Page 1052-1062, August 2025.
Objective Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, relapsing, inflammatory disease. Management of EGPA predominantly relies on oral corticosteroids (OCS), which are associated with many adverse effects. The phase 3 MIRRA trial demonstrated efficacy and safety of mepolizumab, anti‐interleukin‐5 biologic, for EGPA.
Michael E. Wechsler, Jared Silver, Gerhard Wolff, Robert G. Price, Rejina Verghis, Peter F. Weller, Peter A. Merkel, Paneez Khoury, on behalf of the EGPA Mepolizumab Open‐Label Extension Study Group, Arnaud Bourdin, Pascal Chanez, Anoop Chauhan, Vincent Cottin, Gerald Gleich, Berhnard Hellmich, Tomonori Ishii, David Jayne, Jean‐Emmanuel Kahn, Peter Kern, Nader Khalidi, Ina Koetter, Carol Langford, Amy Markezich, Paul Monach, Shamsa Naveed, Peter Oelzner, Kenneth Pinna, Xavier Puechal, Emory H. Robinette, Florence Roufosse, Reinhard Voll, Andrew Schafer, Kaharu Sumino, Masami Taniguchi, Phillip Lieberman   +34 more
wiley   +1 more source

Seasonal variation in incidence and relapse of granulomatosis with polyangiitis: A retrospective cohort study from Central Anatolia. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Soytürk G, Konak HE, Dağlı PA, Ulucaköy RK, Atalar E, Erdoğan EK, Babaoğlu H, Armağan B, Orhan K, Dogan İ, Maraş Y, Omma A, Erten Ş, Küçükşahin O, Güven SC.   +14 more
europepmc   +1 more source

Demographic Disparities in Stroke Occurrence: Insights From an Integrative Review of Emerging Trends

Brain and Behavior, Volume 15, Issue 8, August 2025.
Stroke prevalence increases dramatically among individuals aged 65 years and older, highlighting the significant impact of aging on stroke risk. Gender differences are also apparent, with men experiencing more strokes at younger ages, while women face an increased risk after menopause. Ethnic disparities show that African Americans and Hispanics are at
Gudisa Bereda
wiley   +1 more source

Anti-nuclear cytoplasmic antibody-associated vasculitis and kidney cancer: A mini review. [PDF]

World J Nephrol
Wilding S, Wu HHL, Brown N, Chinnadurai R.   +3 more
europepmc   +1 more source

Immunoglobulin A vasculitis and pustular psoriasis precipitated by Tawon Liar: a case report. [PDF]

J Med Case Rep
Zha M, Ding DD.
europepmc   +1 more source

A Giant Pulmonary Artery Aneurysm in a Young Male With Eisenmenger Syndrome

Clinical Case Reports, Volume 13, Issue 8, August 2025.
ABSTRACT This case highlights a giant pulmonary artery aneurysm with a diameter of 107.7 mm, which is so far one of the most massive pulmonary aneurysms detected in a young person. Management may be extremely challenging in a resource‐poor setting where surgical interventions are not readily available.
Collins Kokuro, Prince Yaw Boahene, Solomon Gyabaah, Kwasi Ankomah, Emmanuel Acheamfour Akowuah, Lambert Tetteh Appiah, Bernard Cudjoe Nkum   +6 more
wiley   +1 more source

B-Cell Depletion in Glomerular and Autoimmune Diseases: Too Much of a Good Thing?

Kidney International Reports
Stephen P. McAdoo
doaj